Regorafenib inhibits ERK signaling and suppresses the growth of sorafenib-resistant cells in human hepatocellular carcinoma

被引：0
|
作者：
Hashiba, Tomomi [1 ]
Yamashita, Taro [1 ]
Okada, Hikari [1 ]
Nio, Kouki [1 ]
Hayashi, Takehiro [1 ]
Nomura, Yoshimoto [1 ]
Yoshida, Mariko [1 ]
Hayashi, Tomoyuki [1 ]
Oishi, Naoki [1 ]
Honda, Masao [1 ]
Kaneko, Shuichi [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med, Gastroenterol, Kanazawa, Ishikawa, Japan
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1953
引用
收藏
页码：1160A / 1160A
页数：1
相关论文
共 50 条
  • [41] Generation and characterization of a sorafenib-resistant hepatocellular carcinoma model from patient-derived tumor xenografts
    Hu, Gang
    Fang, Houshan
    Tang, Xuzhen
    Ouyang, Kedong
    Yang, Xueyan
    Xie, Fubo
    Wang, Ke
    Zhang, Yixin
    Jiang, Zhenzhou
    Zhang, Luyong
    Zhou, He
    Tao, Weikang
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
    Lai, You-Liang
    Wang, Kai-Hung
    Hsieh, Hsing-Pang
    Yen, Wan-Ching
    JOURNAL OF BIOMEDICAL SCIENCE, 2022, 29 (01)
  • [43] The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
    Moharram, Sausan A.
    Shah, Kinjal
    Khanum, Fatima
    Ronnstrand, Lars
    Kazi, Julhash U.
    BLOOD CANCER JOURNAL, 2019, 9 (2)
  • [44] Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling
    Xu, Rushuang
    He, Shan
    Ma, Di
    Liang, Rui
    Luo, Qing
    Song, Guanbin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [45] Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1 cells in vitro
    Chen, Wei-Lung
    Hsieh, Chia-Ling
    Chen, Jiann-Hwa
    Huang, Chih-Sheng
    Chen, Wei-Ting
    Kuo, Yu-Cheng
    Chen, Cheng-Yu
    Hsu, Fei-Ting
    ONCOLOGY LETTERS, 2017, 14 (03) : 3229 - 3234
  • [46] The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
    Sausan A. Moharram
    Kinjal Shah
    Fatima Khanum
    Lars Rönnstrand
    Julhash U. Kazi
    Blood Cancer Journal, 9
  • [47] Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
    Regan-Fendt, Kelly
    Li, Ding
    Reyes, Ryan
    Yu, Lianbo
    Wani, Nissar A.
    Hu, Peng
    Jacob, Samson T.
    Ghoshal, Kalpana
    Payne, Philip R. O.
    Motiwala, Tasneem
    CANCERS, 2020, 12 (10) : 1 - 22
  • [48] Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
    Chen, Zhenghu
    Zhao, Yanling
    Yu, Yang
    Pang, Jonathan C.
    Woodfield, Sarah E.
    Tao, Ling
    Guan, Shan
    Zhang, Huiyuan
    Bieerkehazhi, Shayahati
    Shi, Yan
    Patel, Roma
    Vasudevan, Sanjeev A.
    Yi, Joanna S.
    Muscal, Jodi A.
    Xu, Guo-Tong
    Yang, Jianhua
    ONCOTARGET, 2017, 8 (61) : 104090 - 104103
  • [49] Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Liao, Li-Zhu
    Chen, Chih-Ta
    Li, Nien-Chen
    Lin, Liang-Chun
    Huang, Bo-Shih
    Chang, Ya-Hui
    Chow, Lu-Ping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 20
  • [50] Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
    Chang, Hang-Seok
    Kim, Yonjung
    Lee, So Young
    Yun, Hyeok Jun
    Chang, Ho-Jin
    Park, Ki Cheong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
12345